12 Hrs
Source:
الاقتصادية
Cancer drugs lead pharma earnings
Studies anticipate that cancer drug sales will reach $311 billion annually by 2031, with these medicines approaching a 20% share of the global pharmaceutical market. This growth comes amid rising cancer treatment costs, which exceed $100,000 per patient, and increasing incidence rates as life expectancy rises. Additionally, investments in cancer research and the development of new medications contribute to this growth, although they also raise treatment costs due to the high prices set by pharmaceutical companies for the latest drugs.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)